Bias remorse: are cancer drug trials clear enough on outcomes?
New analysis published in the British Medical Journal has found that almost half of pivotal...
Read More...
Focus:
-
![]()
Pharma Technology Focus: access to PrEP
In this issue: PrEP access in England, taxing Big Pharma, treating endometriosis, and much more.
Read More...
-
![Pharma PR]()
Public image limited: the role of PR in pharma
Appearance is everything, at least that’s how the saying goes, and for pharma companies maintaining...
Read More...
-
![Nobel Prize 2019]()
Nobel Prize 2019: how a breathtaking discovery unlocked new drugs
Three scientists have jointly been awarded the 2019 Nobel Prize in Physiology or Medicine for...
Read More...
-
![Dengvaxia in the Philippines]()
The dengue vaccine dilemma
Pharma giant Sanofi has been mired in controversy in the Philippines after allegations that its...
Read More...
-
![]()
Pharma Technology Focus: improving public relations
In this issue: PR in pharma, paediatric drug development, repatriating API manufacturing, the Irish pharma...
Read More...
-
![]()
Pharma Technology Focus: the dengue dilemma
In this issue: dengue fever vaccine controversy, the problem of manipulated data, fixing a broken...
Read More...
-
![]()
‘Gene-ie in a bottle’ gene therapy opportunity is a treasure trove but CMOs lack capacity
CMOs are recognising the coming demand for gene therapies and have started to build production...
Read More...
-
![]()
Medical device and diagnostic solutions: A life cycle development model that moves your device ahead of the game
The medical device and diagnostic (MDD) industry is experiencing a transformational era due to huge...
Read More...
-
![]()
How mobile health, local sample collections and virtual models are redefining where clinical trials happen
We live in an era where there is an expectation of immediate results. We connect...
Read More...
